Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ansgar Michael Chromik"'
Autor:
Kirstin Reinecke, Sevgi Eminel, Franziska Dierck, Wibke Roessner, Sabine Kersting, Ansgar Michael Chromik, Olga Gavrilova, Ale Laukevicience, Ivo Leuschner, Vicki Waetzig, Philip Rosenstiel, Thomas Herdegen, Christian Sina
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e30985 (2012)
The c-Jun N-terminal kinase (JNK)-inhibiting peptide D-JNKI-1, syn. XG-102 was tested for its therapeutic potential in acute inflammatory bowel disease (IBD) in mice. Rectal instillation of the chemical irritant trinitrobenzene sulfonic acid (TNBS) p
Externí odkaz:
https://doaj.org/article/6e247cd28ca04d6d93eb0f580268ed3c
Autor:
Ekaterina Petrova, Hryhoriy Lapshyn, Dirk Bausch, Jan D'Haese, Jens Werner, Thomas Klier, Natascha C. Nüssler, Jochen Gaedcke, Michael Ghadimi, Waldemar Uhl, Orlin Belyaev, Olga Kantor, Marshall Baker, Tobias Keck, Ulrich F. Wellner, Carsten Crones, Frank Klammer, Matthias Anthuber, Merten Hommann, Klaus Prenzel, Johann Pratschke, Eric P.M. Lorenz, Jörg C. Kalff, Ute Tröbs, Helmut Witzigmann, Hans-Jörg Krämling, Albrecht Stier, Robert Grützmann, Marco Niedergethmann, Matthias Schwarzbach, Wolf Otto Bechstein, Thomas Kraus, Stefan Fichtner-Feigl, Michael Kindler, Thomas Manger, Winfried Padberg, Karl-Jürgen Oldhafer, Ansgar Michael Chromik, Nurettin Albayrak, Matthias Glanemann, Christian Mönch, Hans-Bernd Reith, Christiane Bruns, Anton J. Kroesen, Sven Eisold, Ullrich Fleck, Stefan Post, Detlef Bartsch, Carsten Gutt, Natascha Nüssler, Helmut Friess, Norbert Senninger, Hubert Stein, Franz-Josef Schumacher, Dietmar Lorenz, Pompiliu Piso, Ernst Klar, Jörg-Peter Ritz, Jörg Köninger, Norbert Runkel, Elke Wagler, Christoph Jacobi, Stefan Farkas, Mark Jäger, Christoph-Thomas Germer
Publikováno v:
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 19(1)
Background Postoperative pancreatic fistula (POPF) is a major factor for morbidity and mortality after pancreatic resection. Risk stratification for POPF is important for adjustment of treatment, selection of target groups in trials and quality asses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::702437fecf86d69df94408b1080485f5
https://pubmed.ncbi.nlm.nih.gov/30563791
https://pubmed.ncbi.nlm.nih.gov/30563791
Autor:
Kamran, Harati, Pawel, Slodnik, Ansgar Michael, Chromik, Ole, Goertz, Tobias, Hirsch, Nikolai, Kapalschinski, Ludger, Klein-Hitpass, Jonas, Kolbenschlag, Waldemar, Uhl, Marcus, Lehnhardt, Adrien, Daigeler
Publikováno v:
Anticancer research. 35(2)
Metastatic fibrosarcomas still represent a therapeutic dilemma. Commonly used chemotherapeutic agents such as doxorubicin have been proven effective in fewer than 30% of all cases disseminated of fibrosarcoma. Elderly patients with cardiac disease ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2578af3168662a1f23de648c0a423cb0
https://pubmed.ncbi.nlm.nih.gov/25667456
https://pubmed.ncbi.nlm.nih.gov/25667456
Autor:
Adrien, Daigeler, Daigeler, Adrien, Ludger, Klein-Hitpass, Klein-Hitpass, Ludger, Ingo, Stricker, Stricker, Ingo, Oliver, Müller, Müller, Oliver, Cornelius, Kuhnen, Kuhnen, Cornelius, Ansgar Michael, Chromik, Chromik Ansgar, Michael, Lars, Steinstraesser, Steinstraesser, Lars, Ole, Goertz, Goertz, Ole, Hans-Ulrich, Steinau, Steinau, Hans-Ulrich, Marcus, Lehnhardt, Lehnhardt, Marcus
Publikováno v:
Langenbeck's Archives of Surgery
The new classification of malignant fibrous histiocytoma leaves only a small group of tumors without further line of differentiation, so-called pleomorphic sarcomas, not otherwise specified (NOS) as a pseudo-entity. This study focused on these tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fd64e834d117802aad6085bf0468f3b
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=77954668513
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=77954668513
